ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

NCT02891824 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

614

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: atezolizumab + avastin + platinum-based chemotherapy
DRUG: placebo + avastin + platinum-based chemotherapy

Sponsor

ARCAGY/ GINECO GROUP

Collaborators

[object Object]